[Epoch Times, May 30, 2022](The Epoch Times reporter Li Jing comprehensive report) Beijing Zhongtong Lanbo’s suspected illegal operation in nucleic acid testing has recently been filed for investigation. This is the third nucleic acid testing agency recently notified by Beijing Violations were investigated. At present, the CCP authorities are vigorously promoting the “normalization” of nucleic acid testing, which is considered to be one of the most profitable industries in China.
On May 29, Beijing announced at a press conference that Beijing Zhongtong Lanbo Medical Laboratory (referred to as “Zhongtong Lanbo”) violated the multi-tube mixed inspection situation. Subsequently, Hefei City announced that it would suspend the testing services of Zhongtong Lambo in the city.
The report stated that in order to save costs and speed up the progress, Zhongtong Lanbo seriously violated the nucleic acid testing operation specifications. Even though it knew that excessive mixed testing might lead to inaccurate test results, it still adopted the method of multi-tube mixed testing for testing. The crime of obstructing the prevention and treatment of infectious diseases.
According to reports, Zhongtong Lanbo has been put on file for investigation, and its legal representative Zhang Moumou and others have been investigated.
According to Qixinbao, Beijing Zhongtong Lanbo was established on March 2, 2007. It is a wholly-owned subsidiary of China Tongfu, a Hong Kong-listed company. Its legal representative, manager and executive director are Zhang Huobing.
According to the data, China Tongfu is the largest supplier of radioactive drugs for imaging diagnosis and treatment, urea breath test kits and testers, and radioactive source products for medical and industrial use in China. It is jointly funded and established by China National Nuclear Corporation and other institutions. .
During the epidemic, various medical testing centers under China Tongfu expanded their business to nucleic acid testing. According to the 2021 annual report, various medical testing centers in China have successively opened nucleic acid testing sampling points in Beijing, Chengdu, Wuhan, and Hefei, providing nucleic acid sampling services for individuals, as well as door-to-door sampling services, and also undertook the Winter Olympic Committee. Nucleic acid testing of some personnel, etc.
It is reported that China Tongfu is currently planning to return to A-shares and plan to land on the Shanghai Stock Exchange’s Science and Technology Innovation Board. In addition, China Tongfu’s financial indicators in 2021 have reached record highs, with operating income of 5.144 billion yuan (RMB, the same below), a year-on-year increase of 20.3%; net profit of 673 million yuan, a year-on-year increase of 41.5%; The profit was 336 million yuan, a year-on-year increase of 57.2%.
Three nucleic acid testing institutions were investigated one after another
It is worth noting that three nucleic acid testing institutions in Beijing have been investigated one after another.
In addition to Zhongtong Lanbo, since May 20, two testing institutions, Beijing Pu Shi Medical Laboratory Co., Ltd. and Beijing Jinzhun Medical Laboratory Co., Ltd., have conducted mixed-tube testing on multi-tube testing samples due to violations, or were ordered to do so. Administrative punishment or a case on file for investigation.
Under the CCP authorities’ adherence to the zero-epidemic prevention policy, nucleic acid testing companies have made a fortune from the epidemic. As of April 27, 29 of the 35 companies in the COVID-19 testing sector released their first quarterly reports, and 21 of them had a year-on-year increase in their net profit, accounting for more than 70% of the total. Among them, 11 of them had a year-on-year increase in their net profit of more than 100%. The highest increase was more than 3,000%.
From January to April, the cost of nucleic acid testing was revealed to exceed 100 billion
Recently, the Chinese authorities have vigorously promoted the “normalization” of nucleic acid testing. At present, Beijing, Shanghai, Shenzhen and other major cities have begun to implement normal nucleic acid testing policies. The nucleic acid testing industry is considered one of the most lucrative industries in China.
On May 9, the CCP authorities proposed to establish nucleic acid “sampling circles” in big cities that take 15 minutes to walk.
If normalized nucleic acid testing policies such as the “15-minute nucleic acid sampling circle” are implemented in large cities and even the whole country for a long time, what will the market size be?
According to a report by China Business News, the lowest cost scenario is that, assuming that 30% of the population of “big cities” need to participate in testing and testing once every 7 days, the annual cost is 64.669 billion yuan.
In the case of the highest cost, assuming that 100% of the “big city” population needs to participate in the test throughout the year, and the test frequency is once every 48 hours, then the annual cost is 754.47 billion yuan.
Recently, the macro research team of Huachuang Securities said in an estimate of the cost of normalized nucleic acid testing, combined with changes in the amount of testing and unit price changes, estimated that the cost of nucleic acid so far from the epidemic is about 300 billion yuan, of which nearly 150 billion yuan has been spent in the first four months of this year.
According to the above-mentioned research team, about 80% of the normalized nucleic acid costs are borne by medical insurance, and only about 20% are paid by finance at all levels. The national medical insurance still has 3.6 trillion yuan of “surplus food”, enough for the whole people to test every two days for three and a half years.
However, judging from the actual situation of local medical insurance funds, medical insurance funds in some regions, especially in the central and western regions, also appear to be “incapable of bearing the cost of large-scale nucleic acid testing.”
Li Hengqing, an economist and senior auditor based in the United States, also told The Epoch Times that the expenses for nucleic acid testing flow out of the national treasury and into the pockets of the CCP elite. , were taken away by the genetic testing companies, and behind the genetic testing institutions are the white gloves of the CCP elites.”
Responsible editor: Li Qiong#